Advertisement

U.S. markets open in 7 hours 2 minutes

S&P Futures
4,541.50
-29.75(-0.65%)
Dow Futures
35,062.00
-197.00(-0.56%)
Nasdaq Futures
15,084.50
-121.50(-0.80%)
Russell 2000 Futures
2,075.30
-16.80(-0.80%)
Crude Oil
86.06
+0.63(+0.74%)
Gold
1,812.30
-0.10(-0.01%)

Advertisement

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

17.61

-0.84

(-4.55%)

At close: 04:00PM EST

17.01

-0.60

(-3.41%)

After hours:

07:05PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Triple Moving Average Crossover

View all chart patterns

Performance Outlook

Previous Close	18.45
Open	18.18
Bid	0.00 x 1200
Ask	0.00 x 1800
Day's Range	17.60 - 18.33
52 Week Range	15.83 - 31.18
Volume	791,530
Avg. Volume	1,744,760

Market Cap	2.041B
Beta (5Y Monthly)	0.61
PE Ratio (TTM)	21.22
EPS (TTM)	0.83
Earnings Date	Feb 07, 2022 - Feb 11, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	25.50

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Near Fair Value

8% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CORT

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Corcept Therapeutics Incorporat
CORT: Raising target price to $23.00CORCEPT THERAPEUTICS INC has an Investment Rating of BUY; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
Rating
Fair Value
Economic Moat
14 days agoArgus Research

All

News

Press Releases

Research Reports

Zacks
Wall Street Analysts See a 26% Upside in Corcept (CORT): Can the Stock Really Move This High?
The mean of analysts' price targets for Corcept (CORT) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
CORT vs. ZTS: Which Stock Is the Better Value Option?
CORT vs. ZTS: Which Stock Is the Better Value Option?
Simply Wall St.
How Much Of Corcept Therapeutics Incorporated (NASDAQ:CORT) Do Insiders Own?
A look at the shareholders of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) can tell us which group is most...